Protocols
1 protocol(s) meet the specified criteria
Drug: INOTUZUMAB OZOGAMICIN
Protocol No.TitleStatus
A041501-CIRBA Phase III Trial To Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (A Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39) with Newly Diagnosed Precursor B-Cell ALLOpen